Xtant Medical to Announce Third Quarter 2025 Financial Results on November 11, 2025
Rhea-AI Summary
Xtant Medical (NYSE American: XTNT) will release its third-quarter 2025 financial results for the period ended September 30, 2025 before market open on Tuesday, November 11, 2025. Sean Browne, President and CEO, and Scott Neils, Chief Financial Officer, will host a conference call at 8:30 AM ET the same day.
Conference dial-in details: 888-506-0062 (U.S.), international 973-528-0011, passcode 579614. A live webcast will be available at https://www.webcaster5.com/Webcast/Page/3039/52972, and a replay will be posted under Investor Info at https://xtantmedical.com/.
Positive
- None.
Negative
- None.
News Market Reaction – XTNT
On the day this news was published, XTNT declined 8.55%, reflecting a notable negative market reaction. Argus tracked a peak move of +10.9% during that session. Our momentum scanner triggered 2 alerts that day, indicating moderate trading interest and price volatility. This price movement removed approximately $11M from the company's valuation, bringing the market cap to $120M at that time.
Data tracked by StockTitan Argus on the day of publication.
Sean Browne, President and Chief Executive Officer, and Scott Neils, Chief Financial officer, will host a conference call at 8:30am ET on that day.
Conference Details:
Conference Date: Tuesday, November 11, 2025
Conference Time: 8:30 AM ET
Conference Dial-in: 888-506-0062
International Dial-in: 973-528-0011
Passcode: 579614
Conference Call Name: Xtant Medical Q3 2025 Financial Results
Webcast link: https://www.webcaster5.com/Webcast/Page/3039/52972
Following the live call, a replay will be available on the Company's website, https://xtantmedical.com/, under "Investor info."
About Xtant Medical Holdings, Inc.
Xtant Medical's mission of honoring the gift of donation so that our patients can live as full and complete a life as possible, is the driving force behind our company. Xtant Medical Holdings, Inc. (www.xtantmedical.com) is a global medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics serving the chronic and surgical wound care and sports medicine markets, as well as spinal implant systems. Xtant people are dedicated and talented, operating with the highest integrity to serve our customers.
The symbols ™ and ® denote trademarks and registered trademarks of Xtant Medical Holdings, Inc. or its affiliates, registered as indicated in
View original content to download multimedia:https://www.prnewswire.com/news-releases/xtant-medical-to-announce-third-quarter-2025-financial-results-on-november-11-2025-302603814.html
SOURCE Xtant Medical Holdings, Inc.